sulphate), but these devices were not wound with copper wire. This report must be viewed in the context that limb reduction deformities occur in about 1 in 5000 of live births.
We have seen several cases of spontaneous abortion occuring after conception in the presence of an IUD. One such case was an anencephalic fetus of 11 weeks' gestation. As anencephaly and spina bifida are present in about 500 of the spontaneously aborted fetuses we see, 20 the importance of our observation must be tested in larger series of pregnancies occurring with IUDs in situ. Our finding of progressive calcification suggests, however, that any teratogenic effects attributable to copper may be limited to the precalcification period. Nevertheless, despite the reassuring experimental work on rodents and human tissue cultures,21 it is unrealistic on the available evidence to dismiss the possibility of a teratogenic effect from a retained intrauterine device. More information is urgently needed on the outcome of pregnancies complicated by the presence of IUDs.
FUTURE STUDIES
New types of IUD, such as those that depend on the sustained release of progesterone, are being developed. In view of the calcium deposition that may occur the efficiency of such IUDs should be carefully evaluated. A study of drug or copper levels in the cervical mucus while the device is still in situ would be a simple and accurate way of indicating whether the substance was still being released. It might also detect women in whom the deposition of calcium is particularly rapid. Possibly conception in the presence of an IUD that releases metal or a drug is more common in women who suffer rapid calcification. (HBsAg) and the other with nonorgan-specific autoantibodies.1-3
An autoimmune mechanism may be concerned in the pathogenesis of the liver damage in patients with circulating autoantibodies.4 In these patients, however, the meaning and importance of autoimmunity as shown by the presence of non-organ-specific autoantibodies-smooth-muscle antibody (SMA), antinuclear antibody (ANA), and antimitochondrial antibody (AMA)-are uncertain.
The concept of an autoimmune pathogenesis was supported by Meyer zum Buischenfelde and Miescher,-who purified and characterised a liver-specific protein that was later shown to induce chronic liver disease in rabbits. 6 The finding of an autoantibody directed against the hepatocyte membrane in HBsAg-negative chronic active hepatitis7 further supports this theory.
We have tried to elucidate the disease specificity of this livercell-membrane antibody (LMA) by examining patients with acute and chronic liver disease as well as patients with extrahepatic disease, which is often associated with the presence of autoantibodies.
Patients and methods
We studied 635 patients from Mainz and Copenhagen; 361 had various liver diseases and 274 primary non-hepatic diseases. The diagnoses are listed below.
Acute viral type B hepatitis-Twenty-eight patients had acute viral hepatitis proved by biopsy and circulating HBsAg.
Acute non-B hepatitis-Thirty-one patients had acute viral hepatitis proved by biopsy but no circulating HBsAg or antibody (HBsAb).
Resolved 
Discussion
Hopf et al7 found LMA in sera from several patients with HBsAg-negative chronic active hepatitis. LMA may be regarded as an autoantibody since it reacts with the membranes of normal human hepatocytes and may be absorbed with a freshly prepared human liver membrane fraction containing liver-specific protein. The relation between LMA and liver-specific protein, however, has not yet been clarified. We found LMA in over a third of the patients in this group. It is important, however, that 51 of the 55 patients with LMA had HBsAg-negative acute or chronic liver diseases, 46 of them having chronic liver disease.
In contrast to previously described non-organ-specific autoantibodies (ANA, AMA, SMA), LMA was found exclusively in patients with inflammatory liver diseases and in none of the patients with so-called autoimmune diseases such as systemic lupus erythematosus, rheumatoid arthritis, and glomerulonephritis. LMA thus seems to be disease-specific. LMA was found in 10 serum samples without any detectable ANA or SMA, which underlines that it differs from any other autoantibody known.
The uniform finding of LMA in serum samples from patients with HBsAg-negative chronic active hepatitis supports the hypothesis of an autoimmune mechanism, which accords with the previously shown high prevalence of HLA-B8 (HL-A8),9 cell-mediated immunity to the liver-specific protein,'0 and the K-cell cytotoxicity to hepatocytes" in these patients.
From these findings one may differentiate between CALD initiated by an HB-virus infection and HBsAg-negative CALD, in which an autoimmune mechanism seems to be concerned in the pathogenesis. In the last group the initiating trigger mechanism may well be an infection with a virus, but probably not the HBvirus.
Although the exact pathogenic mechanisms of HBsAgnegative, LMA-positive liver diseases remain obscure, it is of practical clinical interest that LMA is an autoantibody exclusively associated with HBsAg-negative acute and chronic liver diseases. Like AMA, which is of diagnostic value in primary biliary cirrhosis, LMA can be used to identify a substantial population within the great heterogeneous group of patients with CALD.
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REPORTS
Value of radiochromium investigation in autoimmune haemolytic anaemia Radioisotopic (5"Cr) labelling of red cells to measure erythrocyte survival and assess the importance of the liver and spleen in the destruction of red cells is now standard practice in haematology laboratories. There is still disagreement, however, on the reliability of surface counting in predicting the outcome of splenectomy in individual patients with haemolytic disease, particularly those with autoimmune haemolytic anaemia. One group found that 51Cr studies identified patients likely to benefit from splenectomy,l but others have found these investigations less reliable.2 We report here the results of such measurements in 12 patients with autoimmune haemolytic anaemia.
Patients, methods, and results
All 12 patients had a direct antiglobulin titre greater than 1/40 and evidence of haemolysis on the basis of normal laboratory criteria. Standard haematological methods were used. The spleen :liver ratio was assessed by body surface measurements, the ratio of organ uptake of radioactivity being measured when half the intravenously injected 5"Cr had left the circulation (t "'Cr). A value greater than 2-5 is generally regarded as predicting a beneficial result from splenectomy.1 The splenic sequestration index (SSI), which is the percentage increment in spleen:heart radioactivity between zero time and tJ-5Cr, was calculated as follows: SSI=R50-Ro x 100, where R50=spleen:heart ratio at tJ5'Cr and Ro = spleen :heart ratio at zero time. A value greater than 100 is believed to indicate moderate to severe red cell sequestration in the spleen.4
Six patients were able to discontinue corticosteroids within two months after splenectomy. Three were men. Their average age was 42 years and the haemoglobin level at presentation ranged from 4-0-9-8 (mean 7 9) g/dl. In five of the six the sensitisation of the red cell was characterised: in four it was IgG alone, in the other IgG and complement. Six patients needed corticosteroids after splenectomy. All were women. Their average age was 52 and presenting haemoglobin levels ranged from 4-11 (mean 7 7) g/dl. In only three of these patients was the sensitisation of the red cells characterised and in all it was due to complement alone. The correlation between the spleen uptake of radioactivity and the results of splenectomy was poor (see figure) . Theoretically the chances of success after splenectomy should be greatest in quadrants C and D and least in the quadrants A and B. But only three of the five patients in quadrants C and D had complete remission after splenectomy. Furthermore, of the five patients lying in quadrant A-the least favourable for splenectomy-three had a complete remission after operation. Spleen: liver ratio Results of splenectomy and correlation of results with spleen: liver ratio at t15'Cr and spleen sequestration index.
